These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6792980)

  • 21. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
    Van der Auwera P
    J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriological studies with cefsulodin (CGP 7174/E), the first antipseudomonal cephalosporin.
    Ullmann U
    J Antimicrob Chemother; 1979 Sep; 5(5):563-7. PubMed ID: 115832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Pfaller M; Bale M; Preston T; Howard W; Koontz F
    Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
    Yamashiro Y; Ogake N; Takahata M; Minami S
    Jpn J Antibiot; 2000 Apr; 53(4):194-200. PubMed ID: 10868299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
    Fernandes CJ; Stevens DA; Ackerman VP
    Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vivo combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa].
    Sato K; Yamashita K; Okachi R
    Jpn J Antibiot; 1986 Jun; 39(6):1487-93. PubMed ID: 3093728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Lerner SA; Dudek EJ; Boisvert WE; Berndt KD
    Rev Infect Dis; 1984; 6 Suppl 3():S678-88. PubMed ID: 6443769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ; Young LS; Hewitt WL
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of various antibiotic combinations using the E-Test method in multiresistant Pseudomonas aeruginosa strains.
    Kocazeybek B; Arabaci U; Erentürk S; Akdur H
    Chemotherapy; 2002 Mar; 48(1):31-5. PubMed ID: 11901254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
    Watanakunakorn C; Glotzbecker C
    J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro activity of cefoperazone and penicillins alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Pot CM; Westerdaal NA
    J Antimicrob Chemother; 1981 Aug; 8(2):101-6. PubMed ID: 6456254
    [No Abstract]   [Full Text] [Related]  

  • 37. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A.
    Girolami RL; Stamm JM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):766-72. PubMed ID: 7447430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Chan E; Zhou S; Srikumar S; Duan W
    Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vitro activity of cefpirome compared with that of other agents.
    Raizes EG; Cantey JR
    J Antimicrob Chemother; 1988 Feb; 21(2):177-81. PubMed ID: 3129388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.